Mai Baalbaki, MSc
Clinical Research Coordinator
Institute for Health Policy Studies
School of Medicine

Publications (3)

Top publication keywords:
Ribonuclease IIIMutationPromoter Regions, GeneticZebrafishGene Expression RegulationPhosphatidylinositolsSequence DeletionMuscular DiseasesCardiomyopathy, DilatedTranscription, GeneticNeovascularization, PathologicHomeodomain ProteinsCell NucleusTelangiectasia, Hereditary HemorrhagicConnectin

• Inactivating mutations in Drosha mediate vascular abnormalities similar to hereditary hemorrhagic telangiectasia.
  Science signaling 2018 Jiang X, Wooderchak-Donahue WL, McDonald J, Ghatpande P, Baalbaki M, Sandoval M, Hart D, Clay H, Coughlin S, Lagna G, Bayrak-Toydemir P, Hata A
• An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of Titin in zebrafish.
  eLife 2015 Zou J, Tran D, Baalbaki M, Tang LF, Poon A, Pelonero A, Titus EW, Yuan C, Shi C, Patchava S, Halper E, Garg J, Movsesyan I, Yin C, Wu R, Wilsbacher LD, Liu J, Hager RL, Coughlin SR, Jinek M, Pullinger…
• The basal transcription complex component TAF3 transduces changes in nuclear phosphoinositides into transcriptional output.
  Molecular cell 2015 Stijf-Bultsma Y, Sommer L, Tauber M, Baalbaki M, Giardoglou P, Jones DR, Gelato KA, van Pelt J, Shah Z, Rahnamoun H, Toma C, Anderson KE, Hawkins P, Lauberth SM, Haramis AP, Hart D, Fischle W, Divecha…